Antithrombin activity in children with chylothorax

Vera Bernet-Buettiker1, Katharina Waldvogel, Vincenzo Cannizzaro

  • 1Division of Neonatology and Intensive Care, University Children's Hospital, Steinwiesstrasse 75, CH-8032 Zurich, Switzerland. vera.bernet@kispi.unizh.ch

Insights

Children with chylothorax after heart surgery experience increased antithrombin loss. This may elevate their risk for thrombosis, suggesting antithrombin substitution could be beneficial.

Area of Science:

  • Pediatric Cardiology
  • Critical Care Medicine
  • Hematology

Background:

  • Chylothorax is a complication following cardiac surgery in children.
  • Antithrombin is a key protein in the coagulation cascade.

Purpose of the Study:

  • To investigate antithrombin levels in children with chylothorax post-cardiac surgery.
  • To assess the association between antithrombin loss and thrombosis risk.

Main Methods:

  • Assayed antithrombin activity in plasma and pleural effusion samples.
  • Compared children with chylous effusion to those with non-chylous effusion.

Main Results:

  • Significantly higher antithrombin activity in chylous pleural effusion compared to non-chylous.
  • Significantly lower antithrombin levels in the plasma of children with chylothorax.
  • Higher incidence of thrombosis in children with chylothorax.

Conclusions:

  • Children with chylothorax exhibit increased antithrombin loss.
  • This loss may predispose them to thrombosis.
  • Consider antithrombin substitution in critically ill children with chylothorax.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...